Component: (Network and Table)
Network
00100 - Statement - Consolidated Balance Sheets
(http://invivotherapeutics.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001292519 (http://www.sec.gov/CIK)
Consolidated Balance SheetsPeriod [Axis]
2016-12-31
2015-12-31
Consolidated Balance Sheets
 
 
ASSETS:
 
 
Current assets:
 
 
Cash and cash equivalents
21,464,000  
14,920,000  
Restricted cash
361,000  
361,000  
Marketable securities
11,577,000  
5,274,000  
Prepaid expenses and other current assets
451,000  
184,000  
Total current assets
33,853,000  
 
20,739,000  
 
Property, equipment and leasehold improvements, net
510,000  
938,000  
Other assets
421,000  
115,000  
Total assets
34,784,000  
 
21,792,000  
 
LIABILITIES AND STOCKHOLDERS' EQUITY:
 
 
Current liabilities:
 
 
Accounts payable
1,011,000  
521,000  
Loan payable, current portion
423,000  
395,000  
Derivative warrant liability
1,314,000  
1,907,000  
Deferred rent, current portion
141,000  
115,000  
Accrued expenses
1,959,000  
374,000  
Total current liabilities
4,848,000  
 
3,312,000  
 
Loan payable, net of current portion
852,000  
1,275,000  
Deferred rent, net of current portion
135,000  
276,000  
Total liabilities
5,835,000  
 
4,863,000  
 
Commitments and contingencies
xsi:nil  
xsi:nil  
Stockholders' equity:
 
 
Common stock, $0.00001 par value, authorized 100,000,000 shares, issued and outstanding 32,044,087 shares at December 31, 2016; and authorized 50,000,000 shares, issued and outstanding 27,555,948 shares at December 31, 2015
1,000  
1,000  
Additional paid-in capital
185,955,000  
150,497,000  
Accumulated deficit
(157,007,000) 
(133,569,000) 
Total stockholders' equity
28,949,000  
 
16,929,000  
 
Total liabilities and stockholders' equity
34,784,000  
 
21,792,000